Areas of Focus

Breast cancer is a complex disease with no simple solution. That's why our researchers are tackling it from every angle. Learn more about our areas of focus and why each is critical to knowing how to fight cancer from the start, slow its progress and one day stop it from occurring altogether.

Treatment

Every cancer is as unique as each patient. Thanks to research, we now know that no two cancers are the same and have evolved from a one-size-fits-all approach to treatment to tailored therapies and more effective drugs. With more personalized treatment comes improved outcomes.

Our researchers know that a treatment’s benefits, as well as its risks, differ for each person. The type of breast cancer, the stage of the disease and the characteristics of the tumor, along with one’s lifestyle and medical history, are all taken into consideration. Our aim? To find the least invasive, most effective option that will minimize adverse effects while maximizing success for each patient. We like to call this “outsmarting cancer.”

Dr. Aaronson’s research is focused on discovery and functions of cancer genes. At the NCI as Chief, Laboratory of Cellular and Molecular Biology, he identified the first normal function of a cancer gene as that of a growth factor, PDGF, and cloned erbB2 (also...

Mohamed received his B.S. degree in Biochemistry in 2000 and his MD, PhD degree in 2008 from the University of Michigan. His early research  focused on developing facile assays to resolve complex fundamental cellular processes. He is trained in genetics,...

Dr. Accordino has been at Columbia University Medical Center since 2012, when she began her Clinical Hematology/Oncology Fellowship.  Since that time, she has worked on a number of research projects related to health outcomes, quality of cancer care, cancer care...

Kathy S. Albain is Professor of Medicine (tenured) at Loyola University Chicago Stritch School of Medicine and is a Dean’s Senior Scholar. As a member of the Division of Hematology/Oncology, she devotes her clinical practice to patients with breast and lung cancer at...

Prasanna G. Alluri, MD, PhD is a Chief Resident in Radiation Oncology at the University of Michigan and a Research Fellow in Translational Oncology in the laboratories of Arul Chinnaiyan, MD, PhD and Dan Hayes, MD. His research interests are focused on understanding...

Dr. Karen Anderson is a translational researcher at the Biodesign Institute at Arizona State University, with a joint appointment as a breast cancer medical oncologist at Mayo Clinic Arizona. Her research focuses on how the immune system can be harnessed to detect and...

Fabrice André MD, PhD, is an oncologist based at Gustave Roussy Cancer Cancer, Villejuif, France. He is Professor of Medicine at University Paris Sud. His BCRF research focuses on the characterisation of molecular alterations in metastatic breast cancers. He is leading...

Michael Andreeff received his MD and PhD from the University of Heidelberg, Germany, and additional training at Memorial Sloan Kettering Cancer Center. He has been a pioneer in flow cytometry since 1971, when he established the first flow cytometry laboratory at the...

Dr. Arteaga is Professor of Medicine and Director of the Simmons Cancer Center at University of Texas, Southwestern Medical Center. He was formally Associate Director for Clinical Research, Director of the Breast Cancer Program, and Director of the Center for Cancer...

Robert Benezra, PhD, is a Member at Memorial Sloan Kettering Cancer in the Department of Cell Biology and a Professor of Biology at Cornell Graduate School of Medical Sciences in New York City. As a postdoctoral fellow he identified the Id proteins as dominant negative...

Wendie A. Berg, MD, PhD, FACR, is Professor of Radiology at Magee-Womens Hospital of UPMC, University of Pittsburgh School of Medicine, and is well known for her role as Study Chair and PI of ACRIN 6666, Screening Breast Ultrasound and MRI in High-Risk Women.  Dr...

Ross Berkowitz, MD is the William H. Baker Professor of Gynecology at Harvard Medical School and the Director of Gynecology and Gynecologic Oncology at Dana-Farber Cancer Institute and Brigham and Women's Hospital. In addition, he is also the Co-Director of the Women's...

Dr. Bertagnolli is a Professor of Surgery at Harvard University Medical School, and an Associate Surgeon at Dana Farber Cancer Institute and Brigham and Women’s Hospital . She is presently the Chief of the Division of Surgical Oncology at Dana Farber/Brigham and Women’...

Dr. Joseph R. Bertino attended Cornell University and Downstate Medical School, SUNY. After internship and residency, he was a Fellow in Hematology and Biochemistry at The University of Washington. In 1961, he joined the faculty at Yale in Pharmacology/Medicine where...

Lewis C. Cantley, PhD, is the Margaret and Herman Sokol Professor and Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College/Ronald P. Stanton Clinical Cancer Program at New York Presbyterian Hospital. Dr. Cantley grew up in West...

Lisa A. Carey, MD is an experienced clinician-scientist, Division Chief of UNC Hematology/Oncology and Lineberger Comprehensive Cancer Center Associate Director for Clinical Research. She has developed and been PI of multiple clinical and translational trials and has a...

Dr. Jennifer Caswell-Jin is a postdoctoral fellow in medical oncology at Stanford University. She attended Harvard College and Harvard Medical School and then completed her residency training in internal medicine at the University of California, San Francisco.Her...

Eduardo Cazap MD, PhD received his medical degree in 1972 from the University of Buenos Aires and completed a residency in Internal Medicine at the Military Central Hospital and the Universidad del Salvador. He is a founder of the Latin American & Caribbean Society...

Sarat Chandarlapaty, MD, PhD, is an Assistant Attending medical oncologist and a Laboratory Head in the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center. He earned his medical degree at the Wake Forest School of Medicine and his PhD at...

Tal Danino, PhD, is an Assistant Professor of Biomedical Engineering and leads the Synthetic Biological Systems Laboratory at Columbia University in the City of New York. He received a PhD in Bioengineering from the University of California, San Diego, focused on...

Dr. Davidson is a world-renowned breast cancer researcher who serves as Senior Vice President and Director of the Clinical Research Division at the Fred Hutchinson Cancer Research Center, President and Executive Director of the Seattle Cancer Care Alliance, and Head of...

Dr. Joseph O. Deasy is Chair of the Department of Medical Physics, and holder of the Enid A. Haupt Endowed Chair in Medical Physics, at Memorial Sloan Kettering Cancer Center, New York.Dr. Deasy is an attending physicist at Memorial Sloan Kettering Cancer Center (MSK...

Sandra Demaria, MD, a native of Turin, Italy, obtained her MD from the University of Turin. She then moved to New York City for her post-doctoral training in immunology as a Damon Runyon-Walter Winchell Cancer Research Fund awardee, followed by a residency in anatomic...

Dr. DeMichele is a Professor of Medicine and Epidemiology at the University of Pennsylvania and holds the Jill and Alan Miller Endowed Professorship in Breast Cancer Excellence. Dr. DeMichele has been the Co-Leader of the Breast Cancer Research Program in the Abramson...

Angelo Di Leo is Head of the Sandro Pitigliani Medical Oncology Department at the Hospital of Prato, Istituto Toscano Tumori, Italy, since September 2003. He trained at the National Cancer Institute in Milan, where he worked for seven years. From 1996 to 2003, he...

Mary L. (Nora) Disis, MD, is the Athena Distinguished Professor of Breast Cancer Research, Associate Dean for Translational Health Sciences in the University of Washington (UW) School of Medicine, Professor of Medicine and Adjunct Professor of Pathology and Obstetrics...

Susan M. Domchek, MD is the Basser Professor in Oncology at the Perelman School of Medicine of the University of Pennsylvania. She serves as Executive Director of the Basser Center for BRCA at the Abramson Cancer Center and Director of the Mariann and Robert MacDonald...

Dr. Joshua Donaldson is an oncology fellow at Johns Hopkins University, where his research focuses on targeted therapy for breast cancer. After graduating summa cum laude from The College of New Jersey, Dr. Donaldson completed his MD/PhD at Thomas Jefferson University...

Professor Mitch Dowsett, FMedSci, PhD, is Head of the Academic Department of Biochemistry and Head of the Centre for Molecular Pathology at the Royal Marsden Hospital; Professor of Biochemical Endocrinology at the Institute of Cancer Research; and Professor of...

Originally from the United Kingdom, Matthew Ellis completed his medical training in the U.K. at the Universities of Cambridge and London.  After 11 years at Washington University in St Louis, Dr. Ellis is the incoming Director of the Lester and Sue Smith Breast...

Dr. Stanislav Emelianov is a Joseph M. Pettit Endowed Chair, Georgia Research Alliance Eminent Scholar, and Professor of Biomedical Engineering and Electrical & Computer Engineering at the Georgia Institute of Technology. He is also appointed at Emory University...

Leisha Emens is an Associate Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center. She received her MD-PhD from Baylor College of Medicine and completed her residency training in Internal Medicine at the University of Texas at Southwestern before...

Dr. Esserman is a surgeon and breast cancer oncology specialist, and is the Director of the Carol Franc Buck Breast Care Center at the University of California, San Francisco (UCSF).  In 1996, she started the Center of Excellence for Breast Cancer Care at...

Carol Fabian received her MD, internal medicine and oncology training from the University of Kansas School of Medicine in Kansas City, Kansas.  Dr. Fabian joined the faculty at the University of Kansas Medical Center in 1977 and currently holds the rank of...

Zhen Fan was awarded his medical degree in 1985 from the Medical School of Shanghai Medical University, one of China’s most prestigious medical schools, and completed additional graduate studies there in 1988. His medical residency and oncology research training were...

John Forbes is Professor of Surgical Oncology, University of Newcastle (Australia); Director, Department of Surgical Oncology, Calvary Mater Newcastle Hospital; and Director of Research, Australia and New Zealand Breast Cancer Trials Group. His breast cancer research...

Dr. Silvia C. Formenti, an international expert in the use of radiation therapy for the treatment of cancer, is Chair of the newly established Department of Radiation Oncology at Weill Cornell Medical College and Radiation Oncologist-in-Chief at New York-Presbyterian/...

Dr. Shridar Ganesan is the Associate Director for Translational Science at the Rutgers Cancer Institute of New Jersey, Chief of the Section of Molecular Oncology, and Associate Professor of Medicine at the Rutgers Robert Wood Johnson Medical School. Dr. Ganesan...

Judy E. Garber, MD, MPH is the Director of the Center for Cancer Genetics and Prevention at Dana-Farber Cancer Institute, Attending physician at the Brigham and Women’s Hospital, and Professor of Medicine at Harvard Medical School.Her interests focus on breast cancer...

Mehra Golshan, MD, a breast surgical oncologist, is the Medical Director for International Oncology Programs at the Dana-Farber/Brigham and Women’s Cancer Center, Dr. Abdul Mohsen and Sultana Al-Tuwaijri Distinguished Chair in Surgical Oncology, and Associate Professor...

Pamela Goodwin has been involved in research relating to host factors in breast cancer for over 25 years. Early in her career, she became intrigued with the possibility that patient-related factors, especially obesity, might impact outcomes of women diagnosed with...

Julie R. Gralow, MD, is the Jill Bennett Endowed Professor of Breast Cancer at the University of Washington (UW) School of Medicine, Director of Breast Medical Oncology at the Seattle Cancer Care Alliance, and Member of the Clinical Research Division at Fred Hutchinson...

Bruce G. Haffty, MD is Professor and Chairman, Department of Radiation Oncology, Rutgers-Robert Wood Johnson Medical School and New Jersey Medical School and Associate Director, Rutgers Cancer Institute of New Jersey. His medical school training, internship, residency...

Daniel Hayes, MD, is the Clinical Director of the Breast Oncology Program at the University of Michigan Comprehensive Cancer Center (UMCCC) and the Stuart B. Padnos Professor of Breast Cancer Research. He received AB (1974) and MS (1977) degrees at Indiana University,...

Dr. Hershman is Professor of Medicine and Epidemiology at Columbia University and is Leader of the Breast Cancer Program of the Herbert Irving Comprehensive Cancer Center. She completed her medical degree at The Albert Einstein College of Medicine where she was Alpha...

Dr. Gabriel Hortobagyi is an internationally recognized expert in clinical and translational research of breast cancer. He is Professor and the Chair Emeritus of the Department of Breast Medical Oncology at the MD Anderson Cancer Center. He was Hematology/Oncology...

Kathryn B. Horwitz, PhD joined the faculty at the University of Colorado after undergraduate studies at Barnard College, graduate studies at the UT Southwestern Medical School and postdoctoral work at UT San Antonio. Research in her laboratory is both basic and...

Dr. Susan Band Horwitz is a Distinguished University Professor at the Albert Einstein College of Medicine. She grew up in Boston and after graduating from Bryn Mawr College, received her PhD in Biochemistry from Brandeis University.Dr. Horwitz has had a continuing...

Hedvig Hricak is Chair of the Department of Radiology, Memorial Sloan Kettering Cancer Center, a member of the Molecular Pharmacology and Chemistry Program, Sloan Kettering Institute, and Professor, Gerstner Sloan Kettering Graduate School of Biomedical Sciences. The...

Mien-Chie Hung, PhD is the Vice President for Basic Research, and Professor and Chair of the Department of Molecular and Cellular Oncology at the University of Texas MD Anderson Cancer Center and a basic scientist with a translational vision. Dr. Hung is a...

Dr. Shelley Hwang, MD, MPH is a Professor of Surgical Oncology, Vice Chair of Research and Chief of Breast Surgery for the Duke Department of Surgery and the Duke University Comprehensive Cancer Center. Her research focus includes breast cancer prevention, identifying...

Terry Hyslop is Professor of Biostatistics and Bioinformatics at Duke University and Director of Biostatistics for the Duke Cancer Institute. Dr. Hyslop has over 20 years of experience as a biostatistician, with methodological interests in the measurement of biomarkers...

Dr. Ince received his PhD in Pharmacology from Cornell and completed clinical training at Massachusetts General Hospital, Brigham and Women's Hospital, and Harvard Medical School. Dr. Ince was a visiting clinical scientist at Massachusetts Institute of Technology, 2000...

James N. Ingle, MD is Professor of Oncology and Foust Professor in Mayo Clinic College of Medicine. He is the leader of breast cancer research in the Mayo Clinic Comprehensive Cancer Center serving as Program Co-Leader of the Women's Cancer Program with responsibility...

Dr. Jaffee is an internationally recognized expert in cancer immunology with specific expertise in the pre-clinical and early clinical development of immunotherapies for breast and pancreatic cancers. She has developed novel vaccine approaches for the treatment of...

Johanna Joyce joined the Ludwig Institute of Cancer Research, University of Lausanne, Switzerland in 2016. Prior to that, she led a lab at Memorial Sloan Kettering Cancer Center, New York, USA for 11 years where she was promoted through the ranks to tenured Professor...

Benita Katzenellenbogen is Swanlund Professor of Physiology, Cell and Structural Biology, and director of a breast cancer research group at the University of Illinois at Urbana-Champaign. She is an internationally known endocrinologist and cancer researcher and has...

Dr. John Katzenellenbogen, Swanlund Professor of Chemistry, directs a research program at the University of Illinois at Urbana-Champaign that spans chemistry, biology, and medical applications with a particular focus on the action of estrogens in breast cancer. He is...

Dr. Seema A. Khan is Professor of Surgery in the Feinberg School of Medicine at Northwestern University, and the Bluhm Family Professor of Cancer Research. She is the Co-leader of the Women’s Cancer Research Program at the Robert H. Lurie Comprehensive Cancer Center....

Thomas Kipps, MD, PhD, is Professor of Medicine, Evelyn and Edwin Tasch Chair in Cancer Research, and Deputy Director of Research Operations at the UC San Diego Moores Cancer Center. He received his MD and PhD. in Immunology from Harvard University and had his...

Marleen Kok received her PhD from the Netherlands Cancer Institute, Amsterdam. Working in the labs of Dr. Laura van ‘t Veer (currently at UCSF) and Dr. Sabine Linn, she tested the predictive value of gene signatures as well as modifications of the Estrogen Receptor to...

Deanna Kroetz, PhD, is Professor of Bioengineering in the School of Pharmacy at University of California, San Francisco. Since 2009, she has been a Member of UCSF’s Helen Diller Family Comprehensive Cancer Center. She serves as Member of the Scientific Advisory Board...

Ian Elliott Krop, MD, PhD, is the Chief of Breast Medical Oncology and the Director of Clinical Research for the Breast Oncology Program at Dana-Farber Cancer Institute. He is also an Associate Professor of Medicine at Harvard Medical School. Dr. Krop is a...

Dr. Lin is a medical oncologist at Dana-Farber Cancer Institute (DFCI) and Assistant Professor of Medicine at Harvard Medical School. Dr. Lin received her medical degree at Harvard Medical School and subsequently completed her residency in Internal Medicine at Brigham...

X. Shirley Liu received PhD in Biomedical Informatics and PhD minor in Computer Science from Stanford University in 2002. She is now Professor of Statistics, Biostatistics and Computational Biology at Harvard University, Director of the Center of Functional Cancer...

Sherene Loi is a medical oncologist specializing in the treatment of breast cancer. She also leads a lab that focuses on genomics and novel therapeutics in breast cancer, particularly to understand the genomic and immune interface in breast cancer patients. Her...

Dr. Cynthia Ma obtained her MD from Beijing Medical University in China and subsequently PhD in Developmental Biology from the University of Cincinnati. She completed her Internal Medicine residency from New Hanover Regional Medical Center at North Carolina followed by...

Dr. Paul Macklin is an applied mathematician in the newly-established Department of Intelligent Systems Engineering at Indiana University. Dr. Macklin works with teams of clinicians, modelers, and biologists to develop and validate sophisticated computer models of...

Ursula A. Matulonis, MD is Medical Director and Disease Center Leader of the Medical Gynecologic Oncology Program at Dana-Farber Cancer Institute and Associate Professor of Medicine at Harvard Medical School. Her research focuses on developing new targeted...

Heather McArthur, MD, MPH is a medical oncologist with a clinical practice dedicated to the care of patients with breast cancer. Her research activities are focused on innovations in the diagnosis and treatment of breast cancer, with a particular interest in novel...

Dr. Hayley McDaid received her PhD from the Queens University of Belfast, where she characterized the role of the cAMP-dependent protein kinase A signaling pathway in breast and ovarian cancer. These studies pioneered her present-day interest in targeted therapies...

Dr. Merghoub received his BA degree from University of Algiers, Algeria, and MS and PhD degrees with highest distinction from University of Paris, France. His thesis work focused on the study of genetic polymorphism in fetal hemoglobin gene in patients with sickle cell...

Gordon B. Mills, MD, PhD, was recruited to The University of Texas M.D. Anderson Cancer Center (MDACC) in 1994, where he holds the rank of Professor with joint appointments in Systems Biology, Breast Medical Oncology and Immunology, and serves as chairman of the...

Tharcisse Mpunga, MD, MSc, has been the Medical Director of Butaro Hospital in Rwanda since 2009. He led the development of Butaro's acclaimed new hospital facility that opened in 2011, serving a predominantly poor, rural population of about 350,000 people in Northern...

Sharyl Nass, PhD, is a scholar at the National Academy of Medicine’s Institute of Medicine where she serves as Director of the National Cancer Policy Forum and Director of the Board on Health Care Services. Over the past 15 years, her work at IOM has focused on topics...

Dr. Larry Norton is Medical Director of the Evelyn H. Lauder Breast Center at Memorial Sloan Kettering Cancer Center. He is a founder of the Breast Cancer Research Foundation and has served as its Scientific Director since the Foundation's inception in 1993.Dr. Norton...

Dr. Olopade's research interests are diverse and include: 1) treatment of breast cancer, especially in young or pregnant women; 2) familial cancers; 3) molecular genetics of cancer; 4) cancer risk assessment and chemoprevention; 5) breast cancer and minority...

Dr. Osborne was born in St. Louis, Missouri and received his AB and his MD from the University of Missouri, both with honors. He completed his internship and residency at Johns Hopkins and followed this with three years as a Clinical Associate at the Medicine Branch of...

Dr. Clodia Osipo received her PhD in Molecular and Cellular Biochemistry from Loyola University in 2002 while working under Dr. Allen Frankfater. Thereafter, she did her post-doctoral fellowship at the Robert H. Lurie Comprehensive Cancer Center of the Feinberg School...

Pier Paolo Pandolfi received his MD and PhD from the University of Perugia, Italy. He received post-graduate training at the National Institute for Medical Research and the University of London in the UK. Dr. Pandolfi presently holds the Reisman Endowed Chair of...

Dr. Park is from Saginaw, MI and received his Bachelor’s degree from The University of Chicago in 1989. He then completed a dual MD-PhD training program at The University of Pennsylvania School of Medicine, graduating in 1995. After completing a residency in Internal...

Dr. Barbara Parker is involved in the studies of novel personalized therapies for the treatment of breast cancer, the impact of diet and lifestyle on breast cancer outcomes, and the quality of life of breast cancer survivors. She is the principal investigator for the...

Dr. Perou is a member of the Lineberger Comprehensive Cancer Center at UNC, and the Scientific Director of the UNC Bioinformatics Core. He received his PhD in Cellular and Molecular Biology from the Department of Pathology at the University of Utah (1996) where he...

Dr. Pierce completed residency in Radiation Oncology at Pennsylvania and was a senior investigator at the National Cancer Institute (NCI). She joined the Department of Radiation Oncology at Michigan in 1992, where she is currently Professor of Radiation Oncology and...

Dr. Peggy Porter, a pathologist and researcher, is a member of the Human Biology and Public Health Sciences Divisions at Fred Hutchinson Cancer Research Center and Professor of Pathology at the University of Washington. As head of the multi-institutional Women’s Cancer...

Simon Powell, MD, PhD is the Enid A. Haupt Professor and Chairman of the Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center. He is a member of the Molecular Biology Program of the Sloan-Kettering Institute, and Weill Cornell Graduate School of...

Dr. Press is a Professor in the Department of Pathology and holds the Harold E. Lee Chair in Cancer Research at the University of Southern California’s Norris Comprehensive Cancer Center. Dr. Press is a board certified pathologist, directs the USC Breast Cancer...

Dr. Rae received a BS in biology from the University of Pittsburgh and PhD in pharmacology from Georgetown University. In graduate school he combined his interest in breast cancer research with cutting-edge aspects of pharmacology including personalized medicine which...

Dr. Katherine Reeder-Hayes is an early career physician investigator with a research focus on breast cancer disparities and the comparative effectiveness of cancer treatments in diverse populations. She received her medical training at the University of Alabama School...

Dr. Meredith Regan is Associate Professor of Medicine, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School. She is the Group Statistician for the International Breast Cancer Study Group (IBCSG), a Swiss non-...

Dr. David Rimm is a Professor in the Department of Pathology at the Yale University School of Medicine with a secondary appointment in Medicine (Oncology). He completed an MD-PhD at Johns Hopkins University Medical School followed by a Pathology Residency at Yale and...

Neal Rosen, MD, PhD, is the Director of the Center for Mechanism-Based Therapeutics at Memorial Sloan Kettering Cancer Center and a Member in the Program in Molecular Pharmacology and Chemistry. His major interests include the study of the key molecular events and...

Hope S. Rugo, MD, is a Professor of Medicine in the Division of Hematology and Oncology at the University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, where she directs Breast Cancer and Clinical Trial Education. Her research interests...

Dr. Sartorius earned her bachelor’s degree from the University of Michigan and PhD from the University of Colorado Health Sciences Center, both in Molecular Biology. She did her postdoctoral work at the University of Colorado Boulder and is currently an Associate...

Maurizio Scaltriti, PhD, is an Associate Laboratory Member in the Human Oncology...

Dr. Schiff is Associate Professor at the Baylor College of Medicine, Sue & Lester Smith Breast Center and the Departments of Medicine and Molecular and Cellular Biology. She is an internationally recognized expert in breast cancer translational research and in...

Stuart J. Schnitt, M.D. is the Chief of Breast Oncologic Pathology for the Dana-Farber/Brigham and Women’s Cancer Center, Associate Director of the Dana-Farber Cancer Institute/Brigham and Women’s Hospital Breast Oncology Program, co-leader of the Dana Farber Harvard...

Dr. Lois Shepherd is a Professor in the Department of Pathology and Molecular Medicine at Queen's University. She completed her medical school training at McGill and spent three years in England where her interest in hematology developed. She completed her training as...

Lawrence N. Shulman, M.D., is the Deputy Director for Clinical Services of the Abramson Cancer Center at the University of Pennsylvania, and Director of their newly formed Center for Global Cancer Medicine.  He has a leadership role in the strategic development of...

George W. Sledge Jr., MD, is Professor and Chief of Medical Oncology at Stanford University Medical Center.  He specializes in the study and treatment of breast cancer and directed the first large, nationwide study on the use of paclitaxel to treat advanced breast...

Dr. Bryan R. Smith is an Instructor in the Department of Radiology and the Molecular Imaging Program at Stanford (MIPS) at Stanford University. He received BS degrees in Physics, Mathematics, and Biomedical Engineering. He was awarded a PhD at The Ohio State University...

Ian E. Smith, MD, FRCP, FRCPE, is Professor of Cancer Medicine at The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom. He is also Head of the Breast Unit at The Royal Marsden Hospital.His initial medical training was in Edinburgh and he...

Annette L. Stanton, PhD, is Professor of Psychology and Psychiatry/Biobehavioral Sciences at the University of California, Los Angeles, senior research scientist at the UCLA Cousins Center for Psychoneuroimmunology, and a member of the Center for Cancer Prevention and...

Sandra M. Swain, MD, FACP is the Medical Director of the Washington Cancer Institute, MedStar Washington Hospital Center, in Washington, DC. She is a Professor of Medicine at Georgetown University and Adjunct Professor of Medicine at F. Edward Hebert School of Medicine...

Dr. Fraser Symmans is Professor and Director of Research Operations in the Department of Pathology at MD Anderson Cancer Center, where he practices Breast Surgical Pathology and Cytopathology and also directs the Breast Cancer Pharmacogenomics Laboratory. He received...

Allen Tannenbaum is an applied mathematician and presently Distinguished Professor of Computer Science and Applied Mathematics & Statistics at the State University of New York at Stony Brook. He is also Visiting Investigator of Medical Physics at Memorial Sloan...

Nadine Tung, MD is the Director of the Cancer Genetics and Prevention Program at Beth Israel Deaconess Medical Center (BIDMC) which she established in 1997 to evaluate patients and families with hereditary cancer syndromes. She is also a breast medical oncologist and a...

Dr. van ’t Veer is a renowned molecular biologist, Principal Investigator of the Athena Breast Health Network at UCSF and Leader of the Breast Oncology Program in the Helen Diller Family Comprehensive Cancer Center. She is the former Head of Diagnostic Oncology at the...

Dr. Anna Vilgelm is a research assistant professor in pharmacology and cancer biology at Vanderbilt University. She received her MD from the Russian State Medical University in Moscow, Russia and her PhD is from the Engelhardt Institute of Molecular Biology in Moscow,...

Robert H. Vonderheide, MD, D. Phil, is Professor of Medicine and the Hanna Wise Professor in Cancer Research at the Perelman School of Medicine at the University of Pennsylvania and an investigator of the Abramson Family Cancer Research Institute. He is a member of the...

Dr. Liewei Wang received her medical degree from FuDan University Medical School, Shanghai, followed by a PhD degree in Pharmacology from the Mayo Clinic.  She trained in a leading national center for pharmacogenomics (PGx) research.  Currently Dr. Wang is...

Dr. Shaomeng Wang's primary research interest is the discovery and development of novel small-molecule therapeutics for the treatment of human breast cancer and other types of cancer focusing on targeting apoptosis and epigenetics pathways. Dr. Wang has built a...

Eric P. Winer, MD, is Professor of Medicine at Harvard Medical School and Chief, Division of Women's Cancers and the Thompson Senior Investigator in Breast Cancer Research at Dana-Farber Cancer Institute. He is also Co-Chair of the Breast Committee of the Alliance...

Dr. Wolchok is Chief of the Melanoma and Immunotherapeutics Service, Attending Physician at Memorial Sloan Kettering Cancer Center (MSKCC). Dr. Wolchok has helped establish MSKCC as a leader in the discovery and treatment of cancers with novel immunotherapies. Dr....

Antonio Wolff is a Professor of Oncology at the Johns Hopkins University School of Medicine, a member of the Breast and Ovarian Cancer Program at the Johns Hopkins Kimmel Comprehensive Cancer Center, and a breast cancer medical oncologist with expertise in clinical...

Dr. Gerburg Wulf is an Associate Professor of Medicine at Harvard Medical School and an Attending Physician in the Breast Oncology Group at Beth Israel Deaconess Medical Center (BIDMC) and the Dana-Farber Harvard Cancer Center (DFHCC).  She received her medical...

Richard Zellars is Professor and Chairman of the Department of Radiation Oncology at Indiana University and the Director of the IUH Radiation Oncology Service line.  Before he joined the IU team in early 2015, he was  an Associate Professor in the Dept. of...